Our study showed that hAM homogenate strongly reduced the expression of Cdc42 and Rac1/2/3 in non-invasive and invasive bladder cancer urothelial cells, while hAM extract had no inhibitory effect. The gene discussed is RAC1; the disease is urinary bladder carcinoma.